Jiang Su Yida Chemical Co.,Ltd

SZSE:300721 Voorraadrapport

Marktkapitalisatie: CN¥2.2b

Jiang Su Yida ChemicalLtd Balans Gezondheid

Financiële gezondheid criteriumcontroles 1/6

Jiang Su Yida ChemicalLtd has a total shareholder equity of CN¥1.2B and total debt of CN¥1.0B, which brings its debt-to-equity ratio to 84.1%. Its total assets and total liabilities are CN¥2.6B and CN¥1.3B respectively. Jiang Su Yida ChemicalLtd's EBIT is CN¥57.1M making its interest coverage ratio 1.3. It has cash and short-term investments of CN¥186.3M.

Belangrijke informatie

84.1%

Verhouding schuld/eigen vermogen

CN¥1.05b

Schuld

Rente dekkingsratio1.3x
ContantCN¥186.33m
AandelenCN¥1.24b
Totaal verplichtingenCN¥1.35b
Totaal activaCN¥2.59b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Jiang Su Yida Chemical Co.,Ltd (SZSE:300721) Held Back By Insufficient Growth Even After Shares Climb 42%

Oct 08
Jiang Su Yida Chemical Co.,Ltd (SZSE:300721) Held Back By Insufficient Growth Even After Shares Climb 42%

There's Been No Shortage Of Growth Recently For Jiang Su Yida ChemicalLtd's (SZSE:300721) Returns On Capital

Sep 28
There's Been No Shortage Of Growth Recently For Jiang Su Yida ChemicalLtd's (SZSE:300721) Returns On Capital

Lacklustre Performance Is Driving Jiang Su Yida Chemical Co.,Ltd's (SZSE:300721) 25% Price Drop

Aug 12
Lacklustre Performance Is Driving Jiang Su Yida Chemical Co.,Ltd's (SZSE:300721) 25% Price Drop

Jiang Su Yida Chemical Co.,Ltd (SZSE:300721) Held Back By Insufficient Growth Even After Shares Climb 36%

May 21
Jiang Su Yida Chemical Co.,Ltd (SZSE:300721) Held Back By Insufficient Growth Even After Shares Climb 36%

Improved Revenues Required Before Jiang Su Yida Chemical Co.,Ltd (SZSE:300721) Stock's 41% Jump Looks Justified

Mar 08
Improved Revenues Required Before Jiang Su Yida Chemical Co.,Ltd (SZSE:300721) Stock's 41% Jump Looks Justified

Analyse van de financiële positie

Kortlopende schulden: 300721's short term assets (CN¥712.8M) do not cover its short term liabilities (CN¥1.2B).

Langlopende schulden: 300721's short term assets (CN¥712.8M) exceed its long term liabilities (CN¥98.4M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 300721's net debt to equity ratio (69.1%) is considered high.

Schuld verminderen: 300721's debt to equity ratio has increased from 55.3% to 84.1% over the past 5 years.

Schuldendekking: 300721's debt is not well covered by operating cash flow (13.8%).

Rentedekking: 300721's interest payments on its debt are not well covered by EBIT (1.3x coverage).


Balans


Ontdek gezonde bedrijven